Completed PHASE4 INTERVENTIONAL 2-arm NCT03477851

Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis (TramIsch)

Evaluation of the Influence of Tramadol Injection Simultaneous With Sciatic Nerve Block on the Duration of Efficient Sensory Blockade in Patients Operated on for Calcaneus Fracture

Sponsor: Medical University of Warsaw

Conditions Foot Fracture Pain, Acute

Interventions Placebo Tramadol Hydrochloride

Updated 7 times since 2018 Last updated: Oct 27, 2021 Started: Jun 15, 2017 Primary completion: Jun 30, 2020 Completion: Dec 30, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03477851, this PHASE4 trial focuses on Foot Fracture and Pain, Acute and remains completed. Sponsored by Medical University of Warsaw, it has been updated 7 times since 2017, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Nov 2021 — Jul 2024 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Jan 2021 — Nov 2021 [monthly]

Unknown Status PHASE4
Apr 2020 — Jan 2021 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Apr 2020 [monthly]

Recruiting PHASE4
Apr 2018 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Jun 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Medical University of Warsaw

Data source: Medical University of Warsaw

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Warsaw, Poland